3LBA Everolimus Added to Exemestane Reduced Bone Markers and Disease Progression in Bone in Postmenopausal Women with Advanced Breast Cancer: Updated Results From the BOLERO-2 Trial

✍ Scribed by M. Gnant; G.N. Hortobagyi; H. Rugo; H.A. Burris; S. Noguchi; K.I. Pritchard; J. Baselga; T. Sahmoud; H. Bauly; M. Piccart

• Book ID: 117662527
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 45 KB
• Volume: 48
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/s0959-8049(12)70688-3